OBIO

6.5806.00%
AL

Andrew Lawrence Taylor

Chief Financial Officer

Mr. Andrew Lawrence Taylor, MBA, is Chief Financial Officer of Orchestra BioMed Holdings, Inc. from June 06, 2023. He joined Orchestra BioMed Holdings, Inc. on June 06, 2023. He had been Chief Financial Officer of Motus GI Holdings, Inc. since August 16, 2017 until June 2, 2023. He served as Director at Avertix Medical, Inc. Mr. Taylor serves as a Director of Angel Medical Systems, Inc. He served as the Chief Financial Officer of Genome Profiling, LLC. Mr. Taylor served as the Chief Financial Officer at Angel Medical Systems, Inc since 2007 until 2017 and served as its President since April 2013 until 2017. Prior to joining Angel Medical, he served as a Practice Leader for AC Lordi Consulting, a national firm, providing finance, accounting and strategy services. Before joining AC Lordi, Mr. Taylor also served as the Chief Financial Officer and Corporate Director of Operations for Safe3w, Inc. from 2001 to 2005. Mr. Taylor also spent working within a number of industries, including technology, banking, airlines, education and life science. From 1999 to 2001, Mr. Taylor served as the Vice President of Finance and Administration of Abridge, Inc. Prior to that, Mr. Taylor was a Senior Finance Associate at Delta Air Lines (NYSE: DAL), from 1998 to 1999. Mr. Taylor is an experienced financial officer and operations executive with a proven record in entrepreneurial start-up, emerging growth and Fortune 500 businesses both in the US and abroad. He earned a high-honors MBA with a concentration in Accounting and Finance from Northeastern University and a B.A. in Political Science and Economics from McGill University. He also has his NASD Securities Licenses Series 7, 63, 55 and is a CFA program Level II candidate.

Positions